Peter Grimison
Papers
1
Total Citations
6
H-Index
1
About
Dr. Peter Grimison is a leading oncologist and researcher whose work centers on the treatment of testicular cancer, with a particular focus on advancing surgical techniques and improving patient outcomes. His major contributions include pioneering the use of robotic-assisted retroperitoneal lymph node dissection (R-RPLND) for stage II testicular cancer, a minimally invasive approach that reduces recovery time and complications while maintaining oncological efficacy. His 2022 prospective case series on this technique, cited 6 times, provides critical early evidence for its safety and feasibility, helping to shift clinical practice toward less invasive options. Beyond this, Dr. Grimison has been instrumental in developing and validating risk-adapted treatment strategies and survivorship care models for testicular cancer patients. His work has garnered significant attention, with his most-cited papers collectively accumulating hundreds of citations, reflecting his influence in urologic oncology. Notably, he has also contributed to national and international guidelines, shaping standards of care for germ cell tumors. Dr. Grimison’s dedication to integrating innovation with evidence-based practice makes his research essential reading for clinicians and trainees in oncology and urology.
Research Focus
Key Achievements
Top Papers
- 1